Astrazeneca plc
NASDAQ: AZN
$63.87
+$0.67 (+1.1%)
Closing Price on November 21, 2024
AZN Stock Chart and Intraday Price
AZN Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, GB |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 200,284.54M USD |
| Shares Outstanding | 3,100,380,000 |
AZN Articles
These five blue chip dividend stocks would be ideal for investors who had to hold them forever, as they provide reliable streams of passive income.
Published:
George Soros is among the most renowned and controversial hedge fund managers on the planet. Well known for his political affiliations, which are now opposite to a number of politically-charged CEOs...
Published:
Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making $1 billion on the deal. His currency speculation earned him the...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
24/7 Insights With the S&P 500 up 15% year-to-date, a correction could be coming in the third quarter. Stocks that pay dividends will be in big demand when interest rates start to fall over the...
Published:
24/7 Insights Quality dividend stocks outperform non-dividend stocks for shareholders. Dividend stocks can deliver dependable passive income streams. Access 2 legendary, high-yield dividend stocks...
Published:
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Published:
This year’s Artificial Intelligence rally led by the so-called “Magnificent 7” has been fantastic if you owned those stocks. The reality is the great bulk of the S&P 500 is treading water...
Published:
The federal CHIPS Act signed into law by President Joe Biden in August 2022 is offering $52 billion in federal subsidies to boost America’s semiconductor industry. The goal is to reduce U.S....
Published:
Tuesday's top analyst upgrades and downgrades included AstraZeneca, Ballard Power Systems, Bloom Energy, BHP, Cleveland-Cliffs, CrowdStrike, Dow, Nike, Plains All-American Pipeline, Sealed Air and...
Published:
Friday's top analyst upgrades and downgrades included Ally Financial, American Express, AppLovin, AstraZeneca, Coinbase Global, Cognizant Technology Solutions, Comcast, CME, CrowdStrike, Delta Air...
Published:
Before U.S. markets open on Thursday, these three companies will be among those reporting quarterly earnings.
Published:
Wednesday's additional top analyst upgrades and downgrades were on AstraZeneca, Bilibili, Electronic Arts, GoodRx, NetEase, Netflix, Pinterest, U.S. Foods and more.
Published: